Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Insulin Detemir on Glucose Control in Ageing Subjects With Type 2 Diabetes.

NCT00506662 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00506662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00506662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Insulin Detemir on Glucose Control in Ageing Subjects With Type 2 Diabetes.
Lead sponsor
Novo Nordisk A/S
Phase
Phase 4
Overall status
Terminated
Start date
July 31, 2007
Completion date
December 31, 2008
Enrollment
86 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2